These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 9169336

  • 21. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo.
    Kullavanijaya P, Lim HW.
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875
    [Abstract] [Full Text] [Related]

  • 22. Combination of targeted UVB phototherapy and calcipotriene versus targeted UVB alone in psoriasis: systematic review and meta-analysis of randomized controlled trials.
    Gu X, Shen M, Zhao S, Chen X.
    J Dermatolog Treat; 2022 Feb; 33(1):100-104. PubMed ID: 32419530
    [Abstract] [Full Text] [Related]

  • 23. Calcipotriol cream combined with twice weekly broad-band UVB phototherapy: a safe, effective and UVB-sparing antipsoriatric combination treatment. The Canadian Calcipotriol and UVB Study Group.
    Ramsay CA, Schwartz BE, Lowson D, Papp K, Bolduc A, Gilbert M.
    Dermatology; 2000 Feb; 200(1):17-24. PubMed ID: 10681608
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of non-laser, targeted UVB phototherapy alone and in combination with psoralen gel or calcipotriol ointment in the treatment of localized, chronic, plaque-type psoriasis.
    Ozkan I, Köse O, Ozmen I, Arca E.
    Int J Dermatol; 2012 May; 51(5):609-13. PubMed ID: 22515588
    [Abstract] [Full Text] [Related]

  • 25. Positive effect of using calcipotriol ointment with narrow-band ultraviolet B phototherapy in psoriatic patients.
    Rim JH, Choe YB, Youn JI.
    Photodermatol Photoimmunol Photomed; 2002 Jun; 18(3):131-4. PubMed ID: 12207676
    [Abstract] [Full Text] [Related]

  • 26. Preliminary study of the efficacy and tolerability of combination therapy with calcipotriene ointment 0.005% and tacrolimus ointment 0.1% in the treatment of stable plaque psoriasis.
    Tirado-Sánchez A, Ponce-Olivera RM.
    Cutis; 2012 Sep; 90(3):140-4. PubMed ID: 23094314
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Interactions between calcipotriene and ultraviolet light.
    Lebwohl M, Hecker D, Martinez J, Sapadin A, Patel B.
    J Am Acad Dermatol; 1997 Jul; 37(1):93-5. PubMed ID: 9216529
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp.
    Feldman SR, Mills M, Brundage T, Eastman WJ.
    J Drugs Dermatol; 2013 Mar; 12(3):300-6. PubMed ID: 23545912
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches.
    Karrer S, Eholzer C, Ackermann G, Landthaler M, Szeimies RM.
    Dermatology; 2001 Mar; 202(2):108-15. PubMed ID: 11306830
    [Abstract] [Full Text] [Related]

  • 36. Calcipotriol ointment and cream or their vehicles applied immediately before irradiation inhibit ultraviolet B-induced erythema.
    De Rie MA, Di Nuzzo S, Brands S, Hansen AB, Bos JD.
    Br J Dermatol; 2000 Jun; 142(6):1160-5. PubMed ID: 10848740
    [Abstract] [Full Text] [Related]

  • 37. Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years.
    Eichenfield LF, Ganslandt C, Kurvits M, Schlessinger J.
    Pediatr Dermatol; 2015 Jun; 32(1):28-35. PubMed ID: 25412565
    [Abstract] [Full Text] [Related]

  • 38. [Market hyperpigmentation in psoriatic plaque as a sequelae of combination therapy with UVB-311 and calcipotriol].
    Rütter A, Schwarz T.
    Hautarzt; 2000 Jun; 51(6):431-3. PubMed ID: 10907160
    [Abstract] [Full Text] [Related]

  • 39. Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement.
    Lebwohl M, Yoles A, Lombardi K, Lou W.
    J Am Acad Dermatol; 1998 Sep; 39(3):447-50. PubMed ID: 9738781
    [Abstract] [Full Text] [Related]

  • 40. The effects of UVB plus calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis.
    Bourke JF, Iqbal SJ, Hutchinson PE.
    Clin Exp Dermatol; 1997 Nov; 22(6):259-61. PubMed ID: 9604449
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.